About CALDER BIOSCIENCES INC.
Calder Biosciences is a molecular engineering company focused on developing conformationally stabilized prefusion subunit vaccines using its proprietary 3D-Vaxlock technology to protect against viral infections such as RSV, influenza, and Epstein-Barr virus.
Development of conformationally stabilized prefusion subunit vaccinesEngineering site-specific, covalent crosslinks into proteins using 3D-Vaxlock technologyCreation of immunogens that elicit protective immune responses against viral pathogensNovel manufacturing economics with reduced cold chain requirements and lower cost of goods
Is this your company?
Claim CALDER BIOSCIENCES INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim CALDER BIOSCIENCES INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.